Developer docs
API playgroundTry for free, no card

Search company profiles

Shengtong Intelligent Technology

Full company profile

uuid000b7co

Namestring
Shengtong Intelligent Technology
Legal namestring
ST N Technologies Limited
Websiteurl
staitech.cn
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Shengtong Intelligent Technology is a private, Beijing-headquartered company whose firmographic profile describes it as focused on artificial intelligence digital medical platforms. First-party sources associated with the entity (ST N Technologies Limited, stnpath.com, registered in Richmond, CA) present a digital pathology and laboratory services business serving biopharmaceutical research, drug discovery, and pre-clinical sample testing customers. The offering combines laboratory services (slide preparation, digital scanning, IHC/ISH and histopathology) with digital histology services (AI analysis and algorithm services), and is delivered through three software platforms: a Laboratory Animal Breeding System providing closed-loop management of experimental animal breeding; a Digital Pathology Auxiliary Analysis System built on Whole Slide Imaging (WSI) technology; and a Digital Slice Management System described as proprietary-intellectual-property-protected intelligent image analysis.

The business model is enterprise B2B software and services to life sciences customers; pricing is not publicly disclosed. The company raised a tens-of-millions CNY financing round in 2025, reported 300% revenue growth in H1 2025 versus the entire prior year, and is reported to have received orders from SoftBank and Transsion for smart glasses products. This latter activity sits in tension with the pathology product portfolio and appears, based on the input's own commentary, to reflect an entity-confusion between the smart glasses venture (associated with former Gionee core founders) and ST N Technologies Limited. The company has no disclosed management team, headcount, or geographic footprint beyond the Beijing parent and a US contact presence.

Grounded only in the provided sources: the company's verifiable identity is a small, early-stage AI-enabled pathology software and laboratory services vendor that has recently raised growth capital and is reporting triple-digit revenue growth, while one source block describes a separate or potentially conflated smart glasses business with named enterprise customers.

Short descriptiontext

Beijing-based private AI software company developing digital pathology, laboratory animal breeding, and digital slice management platforms for biopharmaceutical research, drug discovery, and pre-clinical sample testing customers in the life sciences sector.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
digital pathology software, AI medical platforms, laboratory information systems, histopathology analysis, drug discovery services
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAMAGAK
Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Health Digital Platforms (Practice Mgmt, Tele-vet)
SECONDARYHLAMAGAH
Clinical Decision Support & Workflow Automation (Protocols, Templates, AI Scribing)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Health Digital Platforms (Practice Mgmt, Tele-vet)
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Software Publishers5132
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Digital Pathology Software
No data
Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Shengtong Intelligent Technology develops AI-powered digital pathology software platforms and provides supporting laboratory and digital histology services for biopharmaceutical research, drug discovery, and pre-clinical sample testing. Its three flagship software platforms are the Laboratory Animal Breeding System (closed-loop management of breeding, feeding, research, sales with full traceability), the Digital Pathology Auxiliary Analysis System (built on Whole Slide Imaging), and the Digital Slice Management System (proprietary-IP intelligent image analysis). Complementary services include slide preparation, digital scanning, IHC/ISH and histopathology, AI analysis, and algorithm services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ST N Technologies Limited offers laboratory and digital histology services and products. The company provides laboratory services including slide preparation, digital scanning, and in situ detection (IHC/ISH) and histopathology services. Their digital histology offerings include AI analysis and algorithm services. The product portfolio consists of three main software platforms: Laboratory Animal Breeding System (for managing experimental animal breeding operations), Digital Pathology Auxiliary Analysis System (using Whole Slide Imaging for digital pathology), and Digital Slice Management System (intelligent image analysis platform). The company focuses on AI-driven pathology solutions for biopharmaceutical research, drug discovery, and pre-clinical sample testing.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Owkin applies AI to medical research and pathology for biopharma drug discovery, with a broader portfolio across multiple therapeutic areas—comparable to ST N's pre-clinical AI pathology focus but at significantly larger scale.

TypeDirect peer
Description

Ibex develops AI-based pathology solutions for cancer detection and clinical decision support, comparable to ST N's AI-driven tissue recognition and diagnostic support tools.

3Aignostics
TypeEmerging player
Description

Aignostics builds AI-based pathology solutions for biopharma research, with a focus on foundation models for histopathology—comparable to ST N's AI-driven pathology analysis platform for drug discovery.

TypeDirect peer
Description

Proscia provides a digital pathology software platform with AI-ready workflows for research and clinical use, closely aligned with ST N's Digital Pathology Auxiliary Analysis and Digital Slice Management platforms.

TypeRegional player
Description

KFBIO is a leading Chinese digital pathology scanner and AI software provider serving China-based hospitals and research institutions, directly comparable to ST N as a regional competitor in the same geography.

TypeDirect peer
Description

3DHISTECH provides whole slide scanning hardware and digital pathology software for clinical and research use, comparable to ST N's WSI-based digital pathology platform.

TypeDirect peer
Description

Paige builds AI-driven digital pathology solutions for cancer diagnosis and biopharma, with FDA-authorized products. Directly comparable to ST N's whole slide imaging and AI analysis offerings for pathology.

TypeDirect peer
Description

PathAI develops AI-powered pathology software for both clinical diagnostics and biopharma research, directly comparable to ST N's digital pathology AI analysis platform targeting drug discovery and pre-clinical workflows.

TypeDirect peer
Description

Visiopharm offers AI-driven image analysis and workflow software for digital pathology, serving pharma and research customers—directly comparable to ST N's histopathology AI and lab workflow tools.

TypeDirect peer
Description

Indica Labs provides digital pathology image analysis software (HALO platform) used widely in pharma research and pre-clinical studies, directly comparable to ST N's AI analysis and digital slice management products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Shengtong Intelligent Technology

Digital Pathology Softwarestaitech.cn

Beijing-based private AI software company developing digital pathology, laboratory animal breeding, and digital slice management platforms for biopharmaceutical research, drug discovery, and pre-clinical sample testing customers in the life sciences sector.

What Shengtong Intelligent Technology does

Shengtong Intelligent Technology is a private, Beijing-headquartered company whose firmographic profile describes it as focused on artificial intelligence digital medical platforms. First-party sources associated with the entity (ST N Technologies Limited, stnpath.com, registered in Richmond, CA) present a digital pathology and laboratory services business serving biopharmaceutical research, drug discovery, and pre-clinical sample testing customers. The offering combines laboratory services (slide preparation, digital scanning, IHC/ISH and histopathology) with digital histology services (AI analysis and algorithm services), and is delivered through three software platforms: a Laboratory Animal Breeding System providing closed-loop management of experimental animal breeding; a Digital Pathology Auxiliary Analysis System built on Whole Slide Imaging (WSI) technology; and a Digital Slice Management System described as proprietary-intellectual-property-protected intelligent image analysis.

The business model is enterprise B2B software and services to life sciences customers; pricing is not publicly disclosed. The company raised a tens-of-millions CNY financing round in 2025, reported 300% revenue growth in H1 2025 versus the entire prior year, and is reported to have received orders from SoftBank and Transsion for smart glasses products. This latter activity sits in tension with the pathology product portfolio and appears, based on the input's own commentary, to reflect an entity-confusion between the smart glasses venture (associated with former Gionee core founders) and ST N Technologies Limited. The company has no disclosed management team, headcount, or geographic footprint beyond the Beijing parent and a US contact presence.

Grounded only in the provided sources: the company's verifiable identity is a small, early-stage AI-enabled pathology software and laboratory services vendor that has recently raised growth capital and is reporting triple-digit revenue growth, while one source block describes a separate or potentially conflated smart glasses business with named enterprise customers.

Shengtong Intelligent Technology firmographics

Firmographics
Name
Shengtong Intelligent Technology
Legal name
ST N Technologies Limited
Website
https://staitech.cn
Company type
Private
Founded year
2021
Operating status
Operating
Short description
Beijing-based private AI software company developing digital pathology, laboratory animal breeding, and digital slice management platforms for biopharmaceutical research, drug discovery, and pre-clinical sample testing customers in the life sciences sector.
Ownership category
akta.pro rank

Shengtong Intelligent Technology industry classification

Industry
Product category
Digital Pathology Software
NAICS
Medical and Diagnostic Laboratories (62151), Software Publishers (5132)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAMAGAK
Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Health Digital Platforms (Practice Mgmt, Tele-vet)
SECONDARYHLAMAGAH
Clinical Decision Support & Workflow Automation (Protocols, Templates, AI Scribing)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Health Digital Platforms (Practice Mgmt, Tele-vet)

Keywords

  • Digital pathology software
  • AI medical platforms
  • Laboratory information systems
  • Histopathology analysis
  • Drug discovery services

Where Shengtong Intelligent Technology is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Markets served

Shengtong Intelligent Technology business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Shengtong Intelligent Technology product offering

Product offering

Core offering

Shengtong Intelligent Technology develops AI-powered digital pathology software platforms and provides supporting laboratory and digital histology services for biopharmaceutical research, drug discovery, and pre-clinical sample testing. Its three flagship software platforms are the Laboratory Animal Breeding System (closed-loop management of breeding, feeding, research, sales with full traceability), the Digital Pathology Auxiliary Analysis System (built on Whole Slide Imaging), and the Digital Slice Management System (proprietary-IP intelligent image analysis). Complementary services include slide preparation, digital scanning, IHC/ISH and histopathology, AI analysis, and algorithm services.

Product overview

ST N Technologies Limited offers laboratory and digital histology services and products. The company provides laboratory services including slide preparation, digital scanning, and in situ detection (IHC/ISH) and histopathology services. Their digital histology offerings include AI analysis and algorithm services. The product portfolio consists of three main software platforms: Laboratory Animal Breeding System (for managing experimental animal breeding operations), Digital Pathology Auxiliary Analysis System (using Whole Slide Imaging for digital pathology), and Digital Slice Management System (intelligent image analysis platform). The company focuses on AI-driven pathology solutions for biopharmaceutical research, drug discovery, and pre-clinical sample testing.

Differentiator

Problem solved

Functional benefit

Companies that use Shengtong Intelligent Technology

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Shengtong Intelligent Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Shengtong Intelligent Technology partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Shengtong Intelligent Technology competitors and assessment

Company assessment

Broad incumbents

  • Owkin: Owkin applies AI to medical research and pathology for biopharma drug discovery, with a broader portfolio across multiple therapeutic areas—comparable to ST N's pre-clinical AI pathology focus but at significantly larger scale.

Direct peers

  • Ibex Medical Analytics: Ibex develops AI-based pathology solutions for cancer detection and clinical decision support, comparable to ST N's AI-driven tissue recognition and diagnostic support tools.
  • Proscia: Proscia provides a digital pathology software platform with AI-ready workflows for research and clinical use, closely aligned with ST N's Digital Pathology Auxiliary Analysis and Digital Slice Management platforms.
  • 3DHISTECH: 3DHISTECH provides whole slide scanning hardware and digital pathology software for clinical and research use, comparable to ST N's WSI-based digital pathology platform.
  • Paige: Paige builds AI-driven digital pathology solutions for cancer diagnosis and biopharma, with FDA-authorized products. Directly comparable to ST N's whole slide imaging and AI analysis offerings for pathology.
  • PathAI: PathAI develops AI-powered pathology software for both clinical diagnostics and biopharma research, directly comparable to ST N's digital pathology AI analysis platform targeting drug discovery and pre-clinical workflows.
  • Visiopharm: Visiopharm offers AI-driven image analysis and workflow software for digital pathology, serving pharma and research customers—directly comparable to ST N's histopathology AI and lab workflow tools.
  • Indica Labs: Indica Labs provides digital pathology image analysis software (HALO platform) used widely in pharma research and pre-clinical studies, directly comparable to ST N's AI analysis and digital slice management products.

Emerging players

  • Aignostics: Aignostics builds AI-based pathology solutions for biopharma research, with a focus on foundation models for histopathology—comparable to ST N's AI-driven pathology analysis platform for drug discovery.

Regional players

  • KFBIO (Konfoong Biotech): KFBIO is a leading Chinese digital pathology scanner and AI software provider serving China-based hospitals and research institutions, directly comparable to ST N as a regional competitor in the same geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Shengtong Intelligent Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Shengtong Intelligent Technology leadership team

Management profile

Number of profiles

Profiles1 record

Shengtong Intelligent Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Shengtong Intelligent Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shengtong Intelligent Technology

What does Shengtong Intelligent Technology do?

Shengtong Intelligent Technology develops AI-powered digital pathology software platforms and provides supporting laboratory and digital histology services for biopharmaceutical research, drug discovery, and pre-clinical sample testing. Its three flagship software platforms are the Laboratory Animal Breeding System (closed-loop management of breeding, feeding, research, sales with full traceability), the Digital Pathology Auxiliary Analysis System (built on Whole Slide Imaging), and the Digital Slice Management System (proprietary-IP intelligent image analysis). Complementary services include slide preparation, digital scanning, IHC/ISH and histopathology, AI analysis, and algorithm services.

Is Shengtong Intelligent Technology a public or private company?

Shengtong Intelligent Technology is a private company. It is classified as venture growth investor backed and is currently operating.

When was Shengtong Intelligent Technology founded?

Shengtong Intelligent Technology was founded in 2021.

Where is Shengtong Intelligent Technology based?

Shengtong Intelligent Technology is headquartered in Beijing, China, in the Asia region.

Who are Shengtong Intelligent Technology's main competitors?

Owkin is listed as a broad incumbent. Direct peers are Ibex Medical Analytics, Proscia, 3DHISTECH, Paige, PathAI, Visiopharm and Indica Labs. Aignostics is listed as an emerging player. KFBIO (Konfoong Biotech) is listed as a regional player.

Does Shengtong Intelligent Technology have an API?

No public API is recorded for Shengtong Intelligent Technology.

What industry is Shengtong Intelligent Technology in?

Shengtong Intelligent Technology's product category is Digital Pathology Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAMAGAK, Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting). Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales